COPD

>

Latest News

AstraZeneca launches THARROS phase 3 trial / image credit ©Sundry Photography/stock.adobe.com
AstraZeneca Launches Phase 3 THARROS Trial of Breztri to Reduce Cardiopulmonary Events in COPD

March 14th 2024

THARROS is the first phase 3 RCT to evaluate an inhaled triple combination therapy for reduction of adverse cardiopulmonary events in people with COPD, says AstraZeneca.

Boehringer Ingelheim Will Cap Out of Pocket Costs for Inhalers at $35 per Month  / image credit inhalers ©beltado/stock.adobe.com
Boehringer Ingelheim Will Cap Out of Pocket Costs for Inhalers at $35 per Month

March 7th 2024

Impact of Regular Exercise on Hospitalization in Patients with COPD: Daily Dose / image credit: ©New Africa/AdobeStock
Impact of Regular Exercise on Hospitalization in Patients with COPD: Daily Dose

February 26th 2024

FDA Accepts Dupilumab sBLA for Priority Review for Treatment of COPD with Type 2 Inflammation / image credit FDA logo courtesy of US FDA
FDA Accepts Dupilumab sBLA for Priority Review for Treatment of COPD with Type 2 Inflammation

February 23rd 2024

COPD Outcomes: Sedentary Lifestyle Significantly Increases Risk for ED Visits, Hospitalization / image credit older couple walking: ©Monkey Business/stock.adobe.com
COPD Outcomes: Sedentary Lifestyle Significantly Increases Risk for ED Visits, Hospitalization

February 19th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.